J.W. Cole Advisors Inc. Purchases Shares of 30,200 Esperion Therapeutics, Inc. (NASDAQ:ESPR)
J.W. Cole Advisors Inc. purchased a new stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 30,200 shares of the biopharmaceutical company’s stock, valued at approximately $66,000. A number of other institutional investors and hedge funds also recently bought […]
J.W. Cole Advisors Inc. purchased a new stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 30,200 shares of the biopharmaceutical company’s stock, valued at approximately $66,000. A number of other institutional investors and hedge funds also recently bought […]
